SurVaxM (SVN53-67/M57-KLH peptide vaccine) / Roswell Park Comprehensive Cancer Center, Fosun Pharma, MimiVax  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SurVaxM (SVN53-67/M57-KLH peptide vaccine) / MimiVax
EAP, NCT04802447: SurVaxM Expanded Access Protocol

Available
N/A
NA
SurVaxM, SVN53-67/M57-KLH
Roswell Park Cancer Institute
Glioblastoma
 
 

Download Options